s-adenosylmethionine has been researched along with gsk3235025 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aranda, R; Bobinski, TP; Briere, DM; Burns, AC; Christensen, JG; Clarine, J; Engstrom, LD; Gunn, RJ; Ivetac, A; Jean-Baptiste, R; Ketcham, JM; Kobayashi, M; Kuehler, J; Kulyk, S; Lawson, JD; Marx, MA; Moya, K; Olson, P; Rahbaek, L; Smith, CR; Thomas, NC; Wang, X; Waters, LM | 1 |
1 other study(ies) available for s-adenosylmethionine and gsk3235025
Article | Year |
---|---|
Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Deoxyadenosines; Female; Gene Deletion; Humans; Mice, Nude; Neoplasms; Phthalazines; Protein Binding; Protein-Arginine N-Methyltransferases; Purine-Nucleoside Phosphorylase; Thionucleosides; Xenograft Model Antitumor Assays | 2022 |